Latest Ratios: P/E Ratio -0.8x · EV/EBITDA 4.1x · ROE -81.3%. (2020–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | $3M | $4M | $11M | — | — | — | — |
| Enterprise Value | $12M | $13M | $35M | — | — | — | — |
| P/E Ratio → | -0.82 | — | — | — | — | — | — |
| P/S Ratio | 0.04 | 0.05 | 0.16 | — | — | — | — |
| P/B Ratio | 0.44 | 0.57 | 4.66 | — | — | — | — |
| P/FCF | 4.80 | 6.16 | — | — | — | — | — |
| P/OCF | 3.26 | 4.18 | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.17 | 0.50 | — | — | — | — |
| EV / EBITDA | 4.08 | 4.39 | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — |
| EV / FCF | — | 19.24 | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 39.2% | 39.2% | 39.0% | 36.5% | 34.8% | 36.0% | 38.0% |
| Operating Margin | -3.2% | -3.2% | -2.6% | -18.9% | -14.4% | -15.7% | -14.0% |
| Net Profit Margin | -5.0% | -5.0% | -6.5% | -17.8% | -11.5% | -16.1% | -14.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | -81.3% | -81.3% | -79.3% | -81.1% | -32.4% | -37.0% | -35.2% |
| ROA | -11.6% | -11.6% | -14.4% | -32.3% | -16.0% | -20.1% | -17.6% |
| ROIC | -8.9% | -8.9% | -5.6% | -32.5% | -18.2% | -16.1% | — |
| ROCE | -11.6% | -11.6% | -8.5% | -46.0% | -24.8% | -22.1% | -19.4% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.62 | 1.62 | 10.72 | 1.59 | 0.85 | 0.60 | 0.86 |
| Debt / EBITDA | 4.00 | 4.00 | — | — | — | — | — |
| Net Debt / Equity | — | 1.21 | 9.86 | 1.43 | 0.72 | 0.53 | 0.84 |
| Net Debt / EBITDA | 2.98 | 2.98 | — | — | — | — | — |
| Debt / FCF | — | 13.08 | — | — | — | — | — |
| Interest Coverage | -2.89 | -2.89 | -2.34 | -22.14 | -138.96 | -37.43 | -17.25 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.79 | 0.79 | 0.81 | 0.69 | 0.86 | 2.45 | 1.25 |
| Quick Ratio | 0.31 | 0.31 | 0.27 | 0.21 | 0.34 | 0.61 | 0.12 |
| Cash Ratio | 0.24 | 0.24 | 0.17 | 0.17 | 0.28 | 0.49 | 0.06 |
| Asset Turnover | — | 2.33 | 2.03 | 1.96 | 0.88 | 1.33 | 1.20 |
| Inventory Turnover | 7.94 | 7.94 | 6.56 | 8.49 | 5.05 | 5.39 | 4.92 |
| Days Sales Outstanding | — | 1.70 | 2.68 | 0.84 | 0.69 | 0.92 | 0.43 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — |
| FCF Yield | 20.8% | 16.2% | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | — | — | — | — |
| Shares Outstanding | — | $17M | $9M | $9M | $10M | $10M | $10M |
Persistent operating losses
According to current market data, HCWC trades at a P/S ratio of 0.04 and an EV/EBITDA of 4.03, suggesting that investors are heavily discounting the company's future earnings potential due to the persistent lack of profitability and the high complexity of its regional retail roll-up strategy.
The extremely low P/S multiple indicates that the market assigns minimal value to the company's top-line revenue, likely viewing the current growth as unsustainable or low-quality. This valuation suggests that the market is pricing in significant execution risk regarding the integration of wellness services into the legacy grocery footprint.
As reported in recent financial statements, HCWC's ROIC has remained consistently negative, reaching -8.1% in 2026Q1, which indicates that the company is currently destroying shareholder value rather than compounding it through its aggressive acquisition of regional organic grocery and wellness assets.
The persistent negative return on capital suggests that the costs associated with maintaining disparate regional banners and corporate overhead are not being offset by the returns generated from the underlying retail operations. Investors should monitor whether management can pivot toward a more capital-efficient model before the existing equity base is further eroded.
Based on historical quarterly data, HCWC's asset turnover has stagnated near 0.55x, revealing that the company is struggling to generate sufficient revenue from its existing asset base, a trend that warrants further investigation into the operational efficiency of its diverse, non-standardized retail store formats.
The inability to improve asset turnover suggests that the 'institutionalized localism' strategy may be creating a drag on operational velocity compared to more centralized peers. Without a significant improvement in inventory management or store-level throughput, the company may continue to face challenges in achieving the scale necessary to reach operating break-even.
As indicated by the company's unique hybrid model, the P/E ratio is a fundamentally misapplied metric for HCWC, as it obscures the transition from a low-margin grocery retail business to a high-margin wellness service platform that requires different valuation benchmarks to accurately assess its long-term viability.
Using P/E to evaluate a company currently experiencing negative net margins provides no insight into the potential value of the wellness service segment. Analysts should instead focus on segment-level contribution margins and customer acquisition costs for the wellness centers to determine if the underlying business model is actually creating value.
Includes 30+ ratios · 6 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying HCWC stock.
Healthy Choice Wellness Corp.'s current P/E ratio is -0.8x. This places it at the 50th percentile of its historical range.
Healthy Choice Wellness Corp.'s current EV/EBITDA is 4.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 4.4x.
Healthy Choice Wellness Corp.'s return on equity (ROE) is -81.3%. The historical average is -57.7%.
Based on historical data, Healthy Choice Wellness Corp. is trading at a P/E of -0.8x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Healthy Choice Wellness Corp. has 39.2% gross margin and -3.2% operating margin.
Healthy Choice Wellness Corp.'s Debt/EBITDA ratio is 4.0x, indicating high leverage. A ratio above 4x may signal elevated financial risk.